Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma

SIMPLE SUMMARY: Defining the specificity and biological sequalae induced by receptors differentiated expressed in multiple myeloma cells are critical for the development of effective immunotherapies based on monoclonal antibodies. Ongoing studies continue to discover new antigens with superior tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Shih-Feng, Xing, Lijie, Anderson, Kenneth C., Tai, Yu-Tzu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657018/
https://www.ncbi.nlm.nih.gov/pubmed/34885245
http://dx.doi.org/10.3390/cancers13236136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657018/
https://www.ncbi.nlm.nih.gov/pubmed/34885245
http://dx.doi.org/10.3390/cancers13236136

Ejemplares similares